How to calculate FIB-4 (Fibrosis-4 index)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To calculate the FIB-4 (Fibrosis-4 index), use the formula: FIB-4 = (Age × AST) / (Platelets × √ALT). This requires four specific values: the patient's age in years, AST (aspartate aminotransferase) in U/L, ALT (alanine aminotransferase) in U/L, and platelet count in 10^9/L. For example, if a patient is 50 years old with AST of 40 U/L, ALT of 36 U/L, and platelets of 200 × 10^9/L, the calculation would be: (50 × 40) / (200 × √36) = 2000 / (200 × 6) = 2000 / 1200 = 1.67. The FIB-4 score helps assess liver fibrosis severity, particularly in patients with chronic liver diseases like hepatitis or fatty liver disease. A score below 1.3 suggests minimal fibrosis, while a score above 3.25 indicates advanced fibrosis, as supported by recent studies 1. This non-invasive test uses readily available laboratory values to help clinicians evaluate liver fibrosis without requiring a liver biopsy, though it should be interpreted alongside other clinical findings and tests for comprehensive liver assessment.

Some key points to consider when using the FIB-4 score include:

  • A FIB-4 score <1.3 can reliably exclude advanced fibrosis in patients with NAFLD, with a negative predictive value of ≥90% 1.
  • Patients with FIB-4 scores between 1.3 and 2.67 are at indeterminate risk and may benefit from further workup to confirm the stage of hepatic fibrosis 1.
  • The FIB-4 score is a useful, inexpensive, first-line assessment of liver fibrosis for use in primary care, and can be used to identify patients who require referral to a hepatologist for further evaluation and management 1.
  • The FIB-4 score should be interpreted in the context of other clinical findings and tests, including liver function tests, imaging studies, and liver biopsy, to provide a comprehensive assessment of liver fibrosis severity.

Overall, the FIB-4 score is a valuable tool for assessing liver fibrosis severity in patients with chronic liver diseases, and can help clinicians make informed decisions about patient management and referral to specialist care.

From the Research

Calculation of FIB-4

To calculate the FIB-4 index, the following formula is used:

  • FIB-4 = (age × AST) / (platelet count × ALT^0.5) 2 This formula takes into account the patient's age, aspartate aminotransferase (AST) levels, platelet count, and alanine aminotransferase (ALT) levels.

Interpretation of FIB-4 Results

The FIB-4 index can be used to predict the severity of liver fibrosis, with higher scores indicating more severe fibrosis. The following cut-off values have been suggested:

  • FIB-4 < 1.3: low risk of fibrosis
  • FIB-4 1.3-2.67: intermediate risk of fibrosis
  • FIB-4 > 2.67: high risk of fibrosis 3 It is essential to note that the FIB-4 index should be used in conjunction with other diagnostic tests, such as the ELF test, to confirm the presence and severity of liver fibrosis.

Clinical Applications of FIB-4

The FIB-4 index has been used in various clinical settings to assess liver fibrosis, including:

  • Chronic hepatitis C 4
  • Chronic hepatitis B 5
  • Nonalcoholic fatty liver disease (NAFLD) 6 The FIB-4 index has been shown to be a useful noninvasive marker for evaluating the severity of liver fibrosis, and its results have been correlated with those of other diagnostic tests, such as Fibroscan.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.